Gedeon Richter - PregLem S.A.
Svetlin Stoilov is a seasoned professional in the pharmaceutical industry, currently serving as a Senior Medical Representative at Gedeon Richter - PregLem S.A. since December 2003. In this role, Svetlin manages a region, engages in negotiations with partners, presents products to healthcare professionals, oversees budgets, collaborates with hospital pharmacists, and organizes various activities. Prior to this position, Svetlin worked as a Trade Representative at Sopharma Trading from January 1996 to December 2003, focusing on client negotiations and sales to pharmacists. Svetlin holds multiple degrees, including a Master's in Health Care/Management from the Medical University of Sofia, a degree in Clinical Pharmacy, and a degree in Pharmacy (Mpharm) from Medicinski universitet - Sofia, in addition to recently obtaining a degree in Psychology from the Ministry of Interior MOI Academy.
This person is not in any offices
Gedeon Richter - PregLem S.A.
PregLem is a Swiss-based specialty biopharmaceutical company dedicated to the development and commercialisation of innovative drugs for women’s reproductive medicine. The company was founded in 2006 by Ernest Loumaye, a specialist in female reproductive medicine, and Eric Rolin, a finance executive in the pharmaceutical industry. PregLem’s name reflects the company’s goal of addressing unmet needs in gynaecology and infertility and its geographical location near Lake Geneva (“Lac Leman” in French). PregLem is supported by a Scientific Advisory Board comprising the heads of reproductive medicine departments from major European academic institutions. PregLem’s team expertise is in Clinical Product Development, Regulatory Affairs and Sales and Marketing of innovative products in women’s health. On 7th October 2010, Gedeon Richter Plc. announced the acquisition of PregLem SA and PregLem became a member of the Richter Group.